We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (270)
- COVID-19 (163)
- Safety monitoring and information (96)
- Legislation (93)
- Compliance and enforcement (61)
- Manufacturing (51)
- Vaping hub (51)
- Labelling and packaging (34)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Import and export (24)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (4)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1245 result(s) found, displaying 1026 to 1050
-
Media releasesInternational Collaborative Review Initiative gives provisional approval of lenvatinib in combination with pembrolizumab
-
News articlesCommonly asked questions about stem cells and regulation
-
Media releasesInfringement notice issued for the alleged advertising of Schedule 4 substances
-
Media releasesInfringement notice issued for the alleged advertising of a cancelled therapeutic good
-
Regulatory decision noticesNew requirements for caffeine and caffeine-containing ingredients within listed medicines
-
Regulatory decision noticesAn amendment to the Therapeutic Goods (Permissible Ingredients) Determination commenced on 2 September 2019.
-
BlogWhen a company makes a medicine, quality is planned for with Good Manufacturing Practice.
-
Safety updatesMedicines Safety Update article
-
News articlesConsidering cosmetic injections? Complete this checklist first
-
News articlesAre you aware of the risks associated with cosmetic injections?
-
Media releasesUpdate on amendments to the Therapeutic Goods Advertising Code (No.2) 2018 and medicines advertising pre-approval
-
Media releasesThe TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices
-
-
Regulatory decision noticesDirection Notice issued to cease advertising of therapeutic goods not entered in the ARTG
-
Regulatory decision noticesDirection Notice issued to cease advertising of unregistered therapeutic goods to consumers
-
News articlesThe TGA will not pursue the development of an alternative quality standard for sunscreen excipient ingredients at this time in 2019.
-
Safety updatesSafety information: regulators review balloon and stent devices used to unblock blood vessels in the legs
-
Media releasesAn individual has been fined for the alleged importation of unapproved cosmetic products after returning from an overseas trip to China
-
Media releasesInfringement notices issued for the alleged importation and advertising of unapproved performance and image enhancing products
-
News articlesInformation for consumers on the use of performance and image enhancing drugs
-
Media releasesInformation on how supplements are regulated in Australia
-
News articlesChanges will be made to the regulation of nappy rash products on 1 January 2020
-
Media releasesImprovements to Consumer Medicine Information
-
Media releasesImportant information about the dangers of using thermography for breast cancer detection
-
BlogIf you have any unwanted medicines, you can safely dispose of them at your local pharmacy.